Abstract
AbstractLiver transplantation is the only established treatment for liver failure. Because of the organ scarsity, liver support strategies are being developed with the aim of either supporting patients with the borderline functional liver cell mass until the organ transplantation or liver regeneration. A bioartificial liver (BAL) consisting of functional liver cells supported by an artificial cell culture material could provide a vital temporary support to patients with liver failure, and could serve as a bridge to transplantation while awaiting a suitable donor. In this paper, we discuss the critical issues for the development of BAL such as bioreactor configuration, mass transfer, cell source and culture technique. The characteristics of membrane BAL systems in clinical, preclinical and in vitro tests are reviewed. Membrane bioreactors used for the generation of in vitro physiological model systems for studying biological mechanisms and testing the efficacy of potential therapies are also discussed. Copyright © 2009 Curtin University of Technology and John Wiley & Sons, Ltd.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
